abrdn Healthcare Investors Shares of Beneficial Interest (HQH)
HQH trades on NYSE in Finance, Finance Companies. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$19.13
-2.99% on the day
Market cap
$905.7M
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | HQH on NYSE |
| Sector | Finance |
| Industry | Finance Companies |
| Country | United States |
| IPO year | 1987 |
| SEC CIK | 0000805267 |
| Incorporated in | MA |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest current report FORM 8-K | 8-K | 2023-09-12 |
| Latest proxy | DEF 14A | 2026-04-07 |
Source: SEC EDGAR submissions feed, 532 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -1.3% |
| 1 month | -11.1% |
| 3 months | -8.8% |
| Year to date | +0.4% |
| 1 year | +0.8% |
| From 52-week high | -22.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Finance Companies
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PRAA | PRA Group Inc. | $20.47 | +2.40% | $770.7M |
| NCZ | Virtus Convertible & Income Fund II Common Shares of Beneficial Interest | $14.28 | -2.26% | $1.1B |
| BST | BlackRock Science and Technology Trust Common Shares of Beneficial Interest | $50.09 | -0.38% | $1.1B |
| JCAP | Jefferson Capital Inc. | $20.54 | +0.93% | $1.2B |
| NCV | Virtus Convertible & Income Fund Common Shares of Beneficial Interest | $15.33 | -1.86% | $1.4B |
| SWRD | Stewards Inc | $2.50 | -4.21% | $564.1M |
| BDJ | Blackrock Enhanced Equity Dividend Trust | $9.59 | -0.10% | $1.7B |
| IQI | Invesco Quality Municipal Income Trust | $8.93 | +0.68% | $472.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier